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Abstract
Background: Cholesterol metabolism is tightly regulated by both cholesterol and its metabolites in the mammalian liver,
but the regulatory mechanism of triacylglycerol (TG) synthesis remains to be elucidated. Lipin, which catalyzes the
conversion of phosphatidate to diacylglycerol, is a key enzyme involved in de novo TG synthesis in the liver via the glycerol-
3-phosphate (G3P) pathway. However, the regulatory mechanisms for the expression of lipin in the liver are not well
understood.
Methodology/Principal Findings: Apolipoprotein E-knock out (apoE-KO) mice were fed a chow supplemented with 1.25%
cholesterol (high-Chol diet). Cholesterol and bile acids were highly increased in the liver within a week. However, the
amount of TG in very low-density lipoprotein (VLDL), but not in the liver, was reduced by 78%. The epididymal adipose
tissue was almost eradicated in the long term. DNA microarray and real-time RT-PCR analyses revealed that the mRNA
expression of all the genes in the G3P pathway in the liver was suppressed in the high-Chol diet apoE-KO mice. In particular,
the mRNA and protein expression of lipin-1 and lipin-2 was markedly decreased, and peroxisome proliferator-activated
receptor-c coactivator-1a (PGC-1a), which up-regulates the transcription of lipin-1, was also suppressed. In vitro analysis
using HepG2 cells revealed that the protein expression of lipin-2 was suppressed by treatment with taurocholic acid.
Conclusions/Significance: These data using apoE-KO mice indicate that cholesterol and its metabolites are involved in
regulating TG metabolism through a suppression of lipin-1 and lipin-2 in the liver. This research provides evidence for the
mechanism of lipin expression in the liver.
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Introduction
A number of transcription factors are involved in the regulation
of lipid metabolism in mammals. The expression levels of genes
related to fatty acids and cholesterol (Chol) homeostasis are
modulated by sterol regulatory element binding protein (SREBP)
[1]. SREBP-1c regulates fatty acid metabolism, whereas Chol
homeostasis is strictly regulated by SREBP-2 [2]. SREBP-2 is
responsible for feedback regulation of the intracellular Chol
concentration through expression of the LDL receptor and
enzymes in the mevalonate pathway [3]. It is suggested that Chol
metabolism and neutral lipid metabolism are interconnected,
although the complete picture of neutral lipid metabolism remains
to be established.
Triacylglycerol (TG) is synthesized via two pathways, the
monoacylglycerol pathway and the glycerol-3-phosphate (G3P)
pathway [4]. The former is predominantly found in the small
intestine, while the latter is present in various tissues, including the
liver. In the G3P pathway, G3P is acylated twice, by glycerophos-
phate acyltransferase (GPAT) and acylglycerophosphate acyltrans-
ferase (AGPAT). Then the resulting phosphatidic acid (PA) is
dephosphorylated to generate diacylglycerol (DG) by the activity of
PA phosphatase, and finally DG is acylated to produce TG by DG
acyltransferase (DGAT). Recently, the genes responsible for the
G3P pathway were identified. The lipin protein family consists of
three isoforms named lipin-1, -2 and -3 in mammals, and was found
to be the Mg
2+-dependent PA phosphatase type 1 (PAP-1) enzyme
that hydrolyzes PA to produce DG [5,6]. Lipin-1, a human
homolog of fld, which underlies lipodystrophy in the mouse [7], is
expressed at high levels in white adipose tissue (WAT), skeletal
muscle and testis, and is also detectable in the liver. In the liver,
lipin-2 is more highly expressed than lipin-1 and functions as a
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much lower in the liver [8]. The liver is the major organ of neutral
lipid metabolism, and it is essential to clarify the regulatory
mechanisms for de novo TG synthesis in the liver to understand the
pathophysiology of metabolic diseases.
The apolipoprotein E-knockout (apoE-KO) mouse is widely
used as a model animal for atherosclerosis accompanied by
spontaneous hypercholesterolemia, due to the reduced clearance
of VLDL and LDL from the circulation [9]. Hyperlipidemic
conditions and atherosclerotic lesion development are accelerated
when these animals are fed a high fat-high Chol diet [10]. It was
also reported that treatment of apoE-KO mice with a diet
supplemented with 1.25% Chol (high-Chol diet) increased the
atherosclerotic lesion size in aortic tissue, as well as plaque
vulnerability [11].
We found a profound decrease in the TG in VLDL fraction in
apoE-KO mice fed a high-Chol diet. The regulatory mechanism
of de novo TG synthesis has not been well reported in the
literature. This led us to investigate regulatory mechanisms of TG
synthesis in the liver that can be controlled by dietary Chol. We
observed that numerous genes were influenced at the transcrip-
tional level by the administration of the high-Chol diet, and found
that Chol intake modulated hepatic TG synthesis through a
significant suppression of lipin-1 and lipin-2. These data raise the
possibility that Chol and its metabolites are factors which regulate
TG metabolism in the liver.
Materials and Methods
Animals and diets
ApoE-KO mice (apoe
2/2:C57BL6), originally obtained from
Charles River Laboratory, were bred in the Center for Laboratory
Animal Science at Showa University. Mice were maintained in a
humidity- and temperature-controlled room with a 12-h light-dark
cycle. At 10 weeks of age, the mice were fed either normal chow
(NIH formula; Oriental Yeast Co., Ltd) or the same chow
containing 1.25% Chol (high-Chol diet) for either 1 week or up to
30 weeks. This study was approved by the Showa University
Ethical Committee on Animal Experiments (approval ID 29041).
Cell culture
HepG2 human hepatoma cells, purchased from RIKEN
BioResource Center (Ibaraki, Japan), were maintained in DMEM
mediumsupplemented withheat-inactivated 10% FBS,100 IU/mL
penicillin and 100 mg/mL streptomycin at 37uC and 5% CO2.T o
investigate the effects of bile acids, the cells (4.0610
5 cells/dish) were
cultured in medium containing lipoprotein-deficient bovine serum
(Sigma). The cells were homogenized and assayed by Western
blotting, as described below.
Plasma lipoproteins
The mice were anesthetized with ethyl ether, and blood was
drawnfromtheinferiorvenacavausingEDTAastheanticoagulant.
The blood was centrifuged at 1,0006 g for 5 min to separate
plasma.The chylomicron,VLDLand LDL fractions wereseparated
by sequential ultracentrifugation using potassium bromide, followed
by dialysis against PBS containing 0.25 mM EDTA [12].
DNA microarray analysis
Microarray experiments were performed in three independent
experiments at each diet. Total RNA was isolated from the liver of
mice using an RNeasy kit (Qiagen). The quality of the extracted
RNA fraction was evaluated using an Agilent 2100 Bioanalyzer
(Agilent). DNA microarray analysis was performed by the one color
labeling method using a Low RNA Input Linear Amplification Kit
(Agilent) following the manufacturer’s instructions. Briefly, a
double-strand cDNA was synthesized by MMLV-RT using a
primercorresponding tothe T7promoter.Acyanine-labeledcRNA
was transcribed using T7 RNA polymerase, and then purified using
the RNeasy mini kit. Yields and labeling efficiency were determined
by ultraviolet absorption using a NanoDrop ND1000 spectropho-
tometer (Thermo Scientific). The labeled cRNA (500 ng) was
fragmented at 60uC for 30 min with fragmentation solution, and
then hybridized to the DNA microarray chip of the Whole Mouse
Genome (4644K) (Agilent) for 18 h at 60uC. After washing, the
microarray chips were scanned with an Agilent microarray scanner.
Individual microarray quality was evaluated using Feature
Extraction software 9.1 (Agilent). Statistical analysis was performed
using Gene Spring GX 7.3 software (Agilent) for normalizing and
filtering. All microarray data is MIAME compliant and the raw and
normalized data have been deposited in the MIAME compliant
database Gene Expression Omnibus (GSE27457).
Real-time RT-PCR analysis
cDNA was synthesized with a QuantiTectH Reverse Transcrip-
tion kit (Qiagen) using 1 mg total RNA. Real-time RT-PCR
analysis was performed using an ABI PRISM7000 (Applied
Biosystems). The primers used are listed in Table S1. The PCR
conditions were 2 min at 50uC and 10 min at 95uC, followed by
40 cycles of 15 sec at 95uC, 20 sec at 60uC and 40 sec at 72uC.
Table 1. Bile acid concentration in the apoE-KO mouse liver.
Bile acid Concentration (pmol/mg)
normal high-Chol
Taurocholic acid 332.89 448.64
Taurodeoxycholic acid 21.60 31.98
Taurochenodeoxycholic acid 15.21 32.27
Tauroursodeoxycholic acid 10.79 14.71
Cholic acid 8.31 8.11
Ursodeoxycholic acid 2.19 2.56
Deoxycholic acid 0.85 0.26
Chenodeoxycholic acid 0.58 1.60
b-Muricholic acid 74.20 102.52
a-Muricholic acid 8.44 19.24
Tauro-a-Muricholic acid 16.82 36.79
Tauro-b-Muricholic acid 0.76 2.01
Glycocholic acid 0.77 0.58
Lithocholic acid 0.09 0.03
Taurolithocholic acid 0.15 0.66
Glycoursodeoxycholic acid 0.12 0.20
Glycochenodeoxycholic acid 0.01 N.D.
Glycolithocholic acid N.D. N.D.
Glycodeoxycholic acid 0.04 N.D.
Glyco-a-muricholic acid N.D. N.D.
Glyco-b-muricholic acid N.D. N.D.
Total 493.82 702.16
Small pieces of liver tissue (0.1 g) from three mice were combined, then the bile
acids in the liver extracts were analyzed by HPLC, as reported previously [14].
N.D.: Not detected.
doi:10.1371/journal.pone.0022917.t001
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normalized on the basis of b-actin content.
Western blotting analysis
Approximately 50 mg of liver were homogenized in lysis buffer
containing 50 mM Tris-HCl (pH 7.5), 250 mM sucrose, 1 mM
EDTA, 1% protease inhibitor cocktail and 10 mM sodium
orthovanadate, and then incubated on ice for 30 min, followed
by filtration. The supernatant was collected and the protein
concentrations were determined by BCA protein assay kit
(Thermo Scientific) with BSA as the standard. An aliquot of the
supernatant (30 mg protein) as well as HepG2 cell lysate was
applied to 12% SDS-PAGE, then transferred to a polyvinylidene
difluoride membrane (ATTO Co., Tokyo, Japan). The membrane
was blocked with 0.1% Tween 20-TBS (TTBS) containing 2%
skim milk and then incubated for 2 h with antibodies (Abs) against
lipin-1 and lipin-2, respectively (R&D Systems, Inc.). The positive
bands were visualized with a horseradish peroxidase-conjugated
second Ab and ECL-plus Western blotting detection reagent (GE
healthcare UK Ltd.), and detected using X-ray film (RX-U; Fuji
Film Co.). The same membrane was reprobed with an Ab against
b-actin (Santa Cruz Biotechnology, Inc.).
Measurement of lipids
Chol and TG were extracted from the liver of mice by the
method of Bligh and Dyer [13], and then dissolved in ethanol. The
amounts of Chol and TG in the liver or in plasma were
determined by enzymatic methods using the Total Chol-test
WakoH and TG-test WakoH (Wako Pure Chemical Co., Osaka,
Japan), respectively. Small pieces of liver tissue (0.1 g) from three
mice were combined, then the bile acids in the liver extracts were
analyzed by HPLC, as reported previously [14].
Statistical analysis
Data are expressed as the mean 6 SEM. Results were analyzed
using Student’s t-test, and statistical significance for all com-
parisons was assigned as * (p,0.05), ** (p,0.01), *** (p,0.005) or
**** (p,0.001).
Results
Effect of a 1 week high-Chol diet on Chol and TG content
in liver and plasma
ApoE-KO mice are known as an animal model of hypercholes-
terolemia, in which the plasma concentrations of Chol are
approximately 14-fold higher than in WT mice, even when
maintained on normal chow (7.2060.16 vs. 0.5060.01 mg/mL).
We examined the effect of dietary Chol intake on lipid metabolism
in apoE-KO mice. ApoE-KO mice at 10 weeks of age were fed
normal chow or the high-Chol diet (1.25% Chol) for one week. The
amount of Chol in the liver increased 4-fold, but TG did not
increase significantly (Fig. 1a, b). The high-Chol diet increased Chol
in the plasmaLDL fraction(Fig. 1c, d). However, the TG content in
the VLDL and LDL fractions was reduced by 78% and 85%,
respectively, compared with the normal chow group (Fig. 1e, f).
These results suggest that VLDL-TG synthesis in the liver is
suppressed in the apoE-deficient liver at an early stage of high-Chol
diet treatment.
Bile acid contents in the liver
Bile acids are the end products of hepatic Chol catabolism. We
extracted bile acids from the mouse liver to perform analysis using
HPLC. The total amount of bile acids in the liver increased by
40% in the high-Chol diet-treated mice compared with those
receiving normal chow (Table 1). These data suggest that the
apoE-KO mice fed the high-Chol diet accumulate both Chol and
bile acids in the liver.
Effect of long-term high-Chol diet on apoE-KO mice
ApoE-KO mice at 10 weeks of age were fed normal chow or the
high-Chol diet for up to 30 weeks. The weight of epididymal WAT
was gradually reduced by the high-Chol diet as early as 1 week,
and then dramatically diminished over 30 weeks (Fig. 2a–c). The
Figure 1. Accumulation of Chol in the liver and reduction of the
plasma TG in the apoE-KO mice fed the high-Chol diet for 1
week. After apoE-KO mice were fed normal chow (white bar) or the
high-Chol diet (black bar) for 1 week, the liver and plasma were
collected (n=3–4 for each group). (a, b) Chol (a) and TG (b) contents in
the liver tissue were determined. (c–f) Lipoproteins in the plasma from
the apoE-KO mice were fractionated by ultracentrifugation. Chol
content in the VLDL (c) and LDL (d) fractions and TG contents in the
VLDL (e) and LDL (f) fractions was determined. *, p,0.05; ***, p,0.005.
doi:10.1371/journal.pone.0022917.g001
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significantly during the 7-week period, but not in those fed the
high-Chol diet (Fig. 2d). These results were not due to changes in
food intake, because food consumption was not reduced during
the period (Fig. 2e).
Influence of high-Chol diet on gene expression in the
liver of apoE-KO mice
To verify the effect of the high-Chol diet on metabolism, we
performed DNA microarray analysis of the liver from apoE-KO
mice after 1 week of high-Chol diet feeding. A great many genes in
the liver (up-regulated: 655 genes, down-regulated: 1,679 genes)
changed their expression levels more than 1.5-fold under the high-
Chol diet compared with normal chow. Table 2 shows the genes
involved in lipid metabolism that exhibited changed mRNA
expression levels as a result of the high-Chol diet. There was
significant repression of sets of genes related to fatty acid
biosynthesis, fatty acid metabolism, Chol biosynthesis, Chol
homeostasis and TG biosynthesis.
Expression of the hepatic G3P pathway was down-
regulated in the liver of high-Chol diet-treated apoE-KO
mice
TG is synthesized via the G3P pathway in the liver. DNA
microarray analysis revealed that the expression of genes in the
G3P pathway, namely GPAT, AGPAT1, lipin-1, lipin-2 and DGAT2,
were reduced in the liver of the apoE-KO mice fed the high-Chol
diet (Table 2). In particular, the lipin-1 gene was the most repressed
(14.3-fold) among all of the genes. The lipin-1 gene produces two
transcripts, lipin-1a and lipin-1b, in the liver by alternative splicing
[15]. The reduced mRNA levels for lipin-1a and -2 were
confirmed by real-time RT-PCR, although lipin-1b did not reach
a significant difference (p=0.06) (Fig. 3a). The mRNA levels of the
other enzymes in the G3P pathway were also reduced significantly,
as shown by real-time RT-PCR (Fig. 3a). Western blotting showed
that the protein levels of both lipin-1 and lipin-2 were markedly
decreased in the liver by the high-Chol diet (Fig. 3b). Note that the
antibody against lipin-1 used binds to lipin-1a and lipin-1b since
the antibody was raised against a domain conserved in the two
isoforms. These data strongly suggest that TG synthesis was
suppressed at the transcriptional level in the liver of apoE-KO
mice fed the high-Chol diet.
Reduction of the mRNA expression levels of transcription
factors and genes involved in lipid metabolism
The effect of the high-Chol diet on mRNA expression levels of
the lipogenic genes, fatty acid synthase (FAS), stearoyl-CoA desaturase 1
(SCD-1) and malic enzyme (ME) was examined (Fig. 4a). The gene
expression of FAS was significantly reduced in the mice fed the
high-Chol diet, but SCD-1 and ME were not. SREBP-1c, which
Figure 2. Effects of the high-Chol diet on apoE-KO mice. (a) The weights of the epididymal white adipose tissues (WAT) in apoE-KO mice fed
normal chow (white bar) or the high-Chol diet (black bar) for up to 30 weeks were measured (n=3–5 for each group). The data are expressed as the
percent of epididymal WAT in the body weight (*p,0.05). (b,c) Epididymal tissues taken from mice fed normal chow (b) or the high-Chol (c) diet for
30 weeks. The brackets indicate the epididymal WAT. Note that WAT was diminished in the mice fed the high-Chol diet. (d) ApoE-KO mice (normal:
n=12, high-Chol: n=14) were fed either the normal chow or high-Chol diet for up to 7 weeks. Statistical significance against the level at week 0 was
calculated by ANOVA. *, P,0.05; **, P,0.01; ***, P,0.005. (e) The amounts of food consumed during each 7 day period in the cages were monitored
(n=2–4 for each cage, n=10–12 mice in one group). The data are expressed as the amount of food consumed in a week per mouse.
doi:10.1371/journal.pone.0022917.g002
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Fold p (n=3)
cholesterol biosynthesis
cytochrome P450, family 51 25.56 ,0.05
3-hydroxy-3-methylglutaryl-CoA reductase (HMG-CoAR) 23.70 ,0.01
hydroxysteroid (17-b) dehydrogenase 7 22.27 ,0.01
phenylalkylamine Ca2+ antagonist binding protein 22.17 ,0.05
farnesyl diphosphate synthetase 22.08 ,0.01
24-dehydrocholesterol reductase 21.92 ,0.05
lanosterol synthase 23.10 ,0.01
cholesterol homeostasis
sterol O-acyltransferase 1 (ACAT) 1.90 ,0.01
ATP-binding cassette, sub-family G (WHITE), member 1 (ABCG1) 2.00 ,0.01
low density lipoprotein receptor (LDLR) 21.85 ,0.01
Transcriptional factor
nuclear receptor subfamily 1, group H, member 4 (FXR) 21.97 0.06
nuclear receptor subfamily 0, group B, member 2 (SHP) 2.03 0.15
hepatic nuclear factor 4, alpha (HNF-4a) 21.42 0.11
peroxisome proliferator activated receptor alpha (PPARa) 22.44 ,0.05
retinoid X receptor alpha (RXRa) 21.72 ,0.05
forkhead box O1 (FOXO1) 22.27 ,0.05
bile acid transporter activity
solute carrier organic anion transporter family, member 1a5 21.57 ,0.01
solute carrier family 10, member 2 23.00 ,0.01
bile acid biosynthesis
cytochrome P450, family 7, subfamily a, polypeptide 1 (CYP7A1) 23.36 0.10
cytochrome P450, family 39, subfamily a, polypeptide 1 (CYP39a1) 21.65 0.15
cytochrome P450, family 8, subfamily b, polypeptide 1 (CYP8b1) 22.86 0.15
fatty acid biosynthesis
fatty acid synthase (FAS) 22.12 0.16
fatty acid desaturase 1 22.17 0.10
acyl-CoA synthetase medium-chain family member 3 21.64 ,0.05
elongation of very long chain fatty acids-like 2 21.96 ,0.05
thromboxane A synthase 1, platelet 2.00 ,0.01
fatty acid metabolism
acyl-CoA oxidase 2, branched chain 1.50 ,0.05
carnitine palmitoyltransferase 1a, liver 23.13 ,0.05
acyl-CoA synthetase long-chain family member 1 21.67 ,0.01
acyl-CoA thioesterase 7 21.59 ,0.01
solute carrier family 27, member 2 21.56 ,0.01
acetyl-CoA acyltransferase 1A 21.54 ,0.01
lipid metabolism
lipoprotein lipase (LPL) 2.80 ,0.01
phospholipase A2, group VII 2.11 ,0.01
hydroxysteroid 11-beta dehydrogenase 1 (11b-HSD1) 21.67 ,0.05
VLDL
apolipoprotein B 21.96 0.10
microsomal triglyceride transfer protein (MTP) 21.64 0.12
TG biosynthesis
acylglycerol-3-phosphate O-acyltransferase 6 (AGPAT6: GPAT4) 21.61 ,0.05
acylglycerol-3-phosphate O-acyltransferase 1 (AGPAT1) 21.52 ,0.01
lipin 1 214.30 ,0.05
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but did not reach statistical significance (Fig. 4a). These data
suggest that the sterol-mediated regulation of fatty acid synthesis is
not sensitive under this condition.
We then investigated the mRNA expression levels of other
transcription factors that regulate lipid metabolism and energy
homeostasis. As shown in Fig. 4b, the high-Chol diet suppressed
the mRNA levels of peroxisome proliferator-activated receptor (PPAR)- c
coactivator-1a (PGC-1a) and PPARa. These results are in good
accordance with the data from the DNA microarray analysis. To
verify the significant reduction in PPARa, the mRNA expression
patterns of PPARa target genes were analyzed. The mRNA levels
of two genes, acyl-coenzyme A oxidase 1 (ACOX1) and carnitine
palmitoyltransferase-1 (CPT-1), which are involved in b-oxidation,
were reduced significantly (Fig. 4b). SREBP-2 and its target genes
such as HMG-CoA reductase and HMG-CoA synthase were signifi-
cantly down-regulated (Fig. 4c). The mRNA expression of farnesoid
X receptor (FXR) was also suppressed (Fig. 4d). These data suggest
that various transcription factors and enzymes related to lipid
metabolism are suppressed in the liver of apoE-KO mice under
the conditions of a high-Chol diet, although fatty acid metabolism
via SREBP-1c is not affected.
Figure 3. Reduction of the expression of genes and proteins involved in the G3P pathway in the liver. (a) The liver was collected from
apoE-KO mice fed normal chow (white bar) or the high-Chol diet (black bar) for 1 week. The mRNA expression levels of genes involved in the G3P
pathway (lipin-1a, lipin-1b, lipin-2, DGAT2, GPAT4 and AGPAT1) were analyzed by real-time RT-PCR (n=7). (b) Changes in the protein levels of lipin-1
and lipin-2 in the liver of apoE-KO mice fed normal chow or the high-Chol diet for 1 week were analyzed by Western blotting. Quantitative analysis is
indicated in the graph (n=3). *, p,0.05; **, p,0.01; ***, p,0.005; ****, p,0.001.
doi:10.1371/journal.pone.0022917.g003
Table 2. Cont.
Fold p (n=3)
lipin 2 22.56 ,0.05
diacylglycerol O-acyltransferase 2 (DGAT 2) 21.92 ,0.05
List of mRNA expression pattern in apoE-KO mice liver changed by high-Chol diet. The mice were fed with either normal chow or high-Chol diet (1.25% Chol) for 1 week.
Cyanine-labbeled cRNA was prepared from total RNA extracted from the mouse liver tissue. DNA microarray analysis was performed as described in Materials and
Methods. The affected genes (,1.5-fold) related to lipid metabolism are listed.
doi:10.1371/journal.pone.0022917.t002
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Chol is scarcely metabolized in peripheral tissues. The major
metabolites of Chol are bile acids generated in the liver. In
addition, certain specialized cells convert Chol into steroid
hormones. We studied the possible involvement of Chol
metabolites on the expression of lipin proteins. It is reported that
the transcription of the lipin-1 gene is regulated by glucocorticoids
(GCs) [16,17] and by PGC-1a [18]. However, corticosterone, an
active form of GC in mouse liver, did not change as a result of the
high-Chol diet (Fig. S1). As shown in Fig. 4b, the high-Chol diet
suppressed mRNA expression of PGC-1a in the liver of apoE-KO
mice, suggesting that lipin-1 expression is down-regulated by a
suppression of PGC-1a.
The regulatory system of lipin-2 expression is poorly understood.
Although PGC-1a is a transcriptional regulator of lipin-1 gene, it is
not involved in lipin-2 expression [19]. Since lipin-2 in addition to
lipin-1 was down-regulated in the high-Chol diet condition, the
effect of bile acids on lipin-2 expression was examined. When
human hepatoma cell line HepG2 cells were treated with
taurocholic acid (TCA), the lipin-2 protein level decreased, while
the lipin-1 protein was not changed under the same conditions
(Fig. 5). These results suggest that there is a bile acid-sensitive
mechanism that regulates lipin-2 expression in the liver.
Discussion
In this study we investigated the regulatory mechanisms of TG
synthesis in the liver of apoE-KO mice fed a high-Chol diet,
because we observed a dramatic reduction in TG content in the
VLDL and LDL fractions under these conditions. These mice also
showed a remarkable loss of epididymal WAT in the course of
long term administration of the high-Chol diet. These observations
led us to focus on the regulatory systems of TG metabolism in the
liver. Genes related to lipid metabolism in the liver were
suppressed, including the G3P pathway. Among them, the
suppression of lipin-1 and -2 was remarkable, which may have
reduced the TG content in lipoproteins. It is reported that lipin-2
is responsible for the major PA phosphatase activity [19] while
hepatic lipin-1 has an important role in VLDL assembly and
secretion in the liver [20,21]. Our current result showing that lipin
could have a significant impact on TG content in VLDL is in
accordance with these studies. In addition, it is suggested that the
accumulation of bile acids in the liver results in the suppression of
lipin-2, which is responsible for TG synthesis.
Lipin consists of three genes, lipin-1, -2 and -3, and the lipin-1
gene produces three proteins, lipin-1a,- 1 b and -1c by alternative
splicing [6,15,22]. In adipocyte, lipin-1a localizes in the nucleus
and lipin-1b localizes in the cytosol [15]. Several studies have
reported that lipin-1 mRNA expression is induced by various
mechanisms, including GCs [16,17] and PGC-1a [18]. Our data
suggest that a reduction of PGC-1a rather than GCs induces the
suppression of lipin-1 expression by the high-Chol diet. Ishimoto et
al. reported that human lipin-1 mRNA and protein were changed
by a depletion and supplementation of cellular sterols in HuH-7
cells in culture, and demonstrated that transcription of the lipin-1
gene is mediated by SREBP-1 [23]. Our study showed strong
reduction of lipin-1a and b protein concomitant with the mRNA
expression of all the enzymes in G3P pathway occurs in vivo by
dietary Chol. Although we cannot rule out the involvement of
SREBP-1 in lipin-1 gene suppression, other regulatory molecules
such as PGC-1a seem to be active under our conditions.
Recent studies reported that lipin-1 has a dual effect on TG
synthesis and gene expression [18,21]. Lipin-1 functions as a
coactivator of PGC-1a and is an inducible amplifier of PPARa
[18], and lipin-1 mRNA levels were found to correlate with the
PPARa mRNA expression level [24]. In this study, we found
potent suppression of the PPARa mRNA level in the apoE-KO
mice fed a high-Chol diet, accompanied by a suppression of its
target genes such as ACOX1 and CPT-1. These data are consistent
with the recent report that neonatal fld mice, in which the lipin-1
gene is mutated, exhibit a significant defect in fatty acid oxidation
and hepatic steatosis [25]. SREBP-1c, another regulator of fatty
acid metabolism, was not significantly changed in its expression
pattern. These data strongly suggest that TG synthesis, in addition
to Chol synthesis and fatty acid oxidation, was down-regulated in
the liver of apoE-KO mice by Chol administration.
The regulatory mechanism of lipin-2 expression has not been
reported. GCs specifically increased mRNA and protein levels of
lipin-1, but not lipin-2 [16,17]. Overexpression and deficiency of
PGC-1a did not change the mRNA or protein levels of lipin-2
[19]. In this study, lipin-2 expression was decreased in the liver by
a high-Chol diet and in HepG2 cells in the presence of bile acids,
Figure 4. Hepatic mRNA expression of lipogenic genes in apoE-
KO mice fed normal chow (white bar) or the high-Chol diet
(black bar) for 1 week. The mRNA expression patterns of (a) SREBP-
1c, FAS, SCD-1 and ME, (b) PGC-1a, PPARa and its target genes (ACOX-1
and CPT-1), (c) SREBP-2 and its target genes (HMG-CoA reductase and
HMG-CoA synthase) and (d) FXR, in the liver were analyzed by real-time
RT-PCR (n=7). *, p,0.05; **, p,0.01; ***, p,0.005; ****, p,0.001.
doi:10.1371/journal.pone.0022917.g004
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liver via lipin-2. This study is, to our knowledge, the first to show a
direct link between lipin-2 down-regulation and bile acids.
Recently, lipin-2 was reported to have an important role as the
major PAP-1 enzyme in the liver responsible for glycerolipid
synthesis. PAP-1 activity is significantly retained in the liver of
adult fld mice, even though other tissues of the mice exhibit
severely decreased PAP-1 activity [19]. RNAi suppression of lipin-
2 markedly reduced PAP-1 activity in hepatocytes from both WT
and fld mice, hence TG synthesis was suppressed despite the fact
that fatty acid availability was high [19]. It is thus possible that (a)
the suppression of both lipin-1 and lipin-2 in apoE-KO mice
regulates TG metabolism through enzymatic and transcriptional
pathways.
Since the amount of bile acids increased by 40% in the liver of
apoE-KO mice fed the high-Chol diet, bile acid-dependent
mechanisms may have led to the TG reduction in our
experimental conditions. It was demonstrated that bile acids
lowered TG synthesis via a reduction of the enzymes involved in
fatty acid synthesis in the liver at a transcriptional level via
activating FXR-SHP-SREBP-1c regulatory cascade. Bile acids
activate FXR to induce SHP synthesis, and SHP suppresses the
transcriptional function of SREBP-1c, leading to the suppression
of lipogenic gene expression [26]. In this study, a significant
reduction of SREBP-1c mRNA was not observed and the mRNA
level of SHP did not change (data not shown), probably because
the mRNA expression of FXR was suppressed by the high-Chol
diet. Zhang et al. previously reported that PGC-1a increases FXR
activity through two pathways, in which PGC-1a increases the
FXR mRNA levels and interacts with FXR to enhance the
transcription of FXR target genes [27]. In our experimental
condition, the significant reduction of PGC-1a level may have led
to a suppression of FXR.
Alternatively, it is reported that administration of bile acids
reduced expression of PPARa-mediated genes, such as ACOX1,
even in the FXR-null mice [28]. It seems that the suppression of
PPARa functions maybe significantunderpathological,ratherthan
physiological, conditions with increased bile acid concentrations. In
our experiments we observed significant suppression of PPARa-
mediated genes, ACOX1 and CPT-1, after high-Chol diet treatment.
Since the amounts of bile acids increased by 40% in the liver, bile
acids might contribute to the changes in transcription profile of
PPARa-mediated genes in the liver by Chol administration.
Stein et al. reported very recently that apoE
2/2 PGC-1a
2/2
double knockout mice had reduced TG content in the VLDL
fraction and a remarkable loss of adipose tissue weight [29]. The
observation corresponds well with the current study, since the
PGC-1a mRNA expression level was reduced in the liver by the
high-Chol diet, and this supports the concept that PGC-1a has an
important role in TG metabolism.
In conclusion, this study demonstrates that apoE-KO mice fed a
high-Chol diet exhibit a significant reduction of plasma TG,
accompanied by an accumulation of hepatic bile acid and
suppressed expression of enzymes involved in the G3P pathway
Figure 5. The effect of bile acids on lipin-1 and -2 protein expression in HepG2 cells. HepG2 cells were cultured in DMEM medium
containing 10% lipoprotein-deficient serum , and TCA (0, 20, and 50 mM) was added for 24 h. Cells were lysed and analyzed by Western blotting.
Quantitative analysis is shown with the graph (n=3). *, p,0.05; **, p,0.01.
doi:10.1371/journal.pone.0022917.g005
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PLoS ONE | www.plosone.org 8 August 2011 | Volume 6 | Issue 8 | e22917required for TG synthesis in the liver. We also found that bile acids
have the ability to suppress lipin-2 expression in the liver. This
study sheds new light on the mechanisms regulating TG synthesis
and Chol metabolism as part of the context of whole-body neutral
lipid homeostasis.
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